Hyperacidity, GERD, and ulcers:
Indications for: Metoclopramide Orally Disintegrating Tabs
Short-term (4–12 weeks) therapy for symptomatic refractory GERD.
Adult Dosage:
Allow tablet to dissolve on tongue. 10–15mg 4 times daily 30mins before meals and at bedtime. Intermittent symptoms: up to 20mg prior to provoking situation; max 12 weeks per therapeutic course. Renal impairment: reduce dose.
Children Dosage:
Not established.
Metoclopramide Orally Disintegrating Tabs Contraindications:
When stimulation of GI motility may be dangerous (eg, obstruction, perforation, or hemorrhage). Pheochromocytoma. Epilepsy. Concomitant drugs which may cause extrapyramidal reactions (eg, antidepressants, antipsychotics, neuroleptics).
Metoclopramide Orally Disintegrating Tabs Warnings/Precautions:
Discontinue if signs/symptoms of tardive dyskinesia develop; risk increases with duration of treatment and total cumulative dose. Parkinsonism. History of depression. Hypertension. CHF. Arrhythmia. Elderly. Pregnancy (Cat.B). Nursing mothers.
Metoclopramide Orally Disintegrating Tabs Classification:
Prokinetic.
Metoclopramide Orally Disintegrating Tabs Interactions:
Hypertensive crisis with MAOIs. Additive sedation with alcohol, other CNS depressants. Antagonized by anticholinergics and narcotics. Monitor insulin use; may diminish gastric and accelerate intestinal absorption of drugs or food.
Adverse Reactions:
Headache, nausea, vomiting, fatigue, somnolence, dizziness, extrapyramidal effects, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, hypertension.
Note:
Formerly known under the brand name Metozolv ODT.
How Supplied:
Contact supplier
Nausea:
Indications for: Metoclopramide Orally Disintegrating Tabs
To relieve symptoms associated with acute and recurrent diabetic gastroparesis.
Adult Dosage:
Allow tablet to dissolve on tongue. 10mg 4 times daily 30mins before meals and at bedtime for 2–8 weeks. Renal impairment: reduce dose.
Children Dosage:
Not established.
Metoclopramide Orally Disintegrating Tabs Contraindications:
When stimulation of GI motility may be dangerous (eg, obstruction, perforation, or hemorrhage). Pheochromocytoma. Epilepsy. Concomitant drugs which may cause extrapyramidal reactions (eg, antidepressants, antipsychotics, neuroleptics).
Metoclopramide Orally Disintegrating Tabs Warnings/Precautions:
Discontinue if signs/symptoms of tardive dyskinesia develop; risk increases with duration of treatment and total cumulative dose. Parkinsonism. History of depression. Hypertension. CHF. Arrhythmia. Elderly. Pregnancy (Cat.B). Nursing mothers.
Metoclopramide Orally Disintegrating Tabs Classification:
Antidopaminergic.
Metoclopramide Orally Disintegrating Tabs Interactions:
Hypertensive crisis with MAOIs. Additive sedation with alcohol, other CNS depressants. Antagonized by anticholinergics and narcotics. Monitor insulin use; may diminish gastric and accelerate intestinal absorption of drugs or food.
Adverse Reactions:
Headache, nausea, vomiting, fatigue, somnolence, dizziness, extrapyramidal effects, parkinsonism, tardive dyskinesia, neuroleptic malignant syndrome, hypertension.
Note:
Formerly known under the brand name Metozolv ODT.
How Supplied:
Contact supplier
